Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR

NCT: NCT07751965 · NOT_YET_RECRUITING

NCT IDNCT07751965
StatusNOT_YET_RECRUITING
Start Date2026-10-30
Completion2032-03-30
SponsorCeric Sàrl (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective study is designed to evaluate the safety and efficacy of Myval THV series in patients with severe symptomatic non- or mild-calcified aortic regurgitation.

Frequently Asked Questions

What is Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR?

Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR is a clinical trial registered under NCT07751965. Current status: NOT_YET_RECRUITING.

What is the status of NCT07751965?

The current status of NCT07751965 (Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR) is: NOT_YET_RECRUITING.

When did Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR start?

Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR started on 2026-10-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑